Abstract submission is now closed
Deadline: 10 MARCH 2015


All participants are invited to submit abstracts on the topics listed in the abstract topics section for presentation at the 25th ECCMID.

The scientific committee will be looking for state-of-the art and late breaking news (that was not available or known by the 2 November extended deadline).

Abstracts may only be submitted online. Abstracts submitted after the deadline of 10 March 2015 will not be considered. In order to standardise the abstract layout we ask you to read the preparation guidelines at this link CAREFULLY! Avoid submission within 48 hours of the deadline for best system performance.

Changes to abstracts that were already submitted can be done by the authors up until the Late-Breaking Abstract Submission Deadline – 10 March 2015 until 23:59 hours CET. No changes will be accepted thereafter (including changes of presenters).

To view and/or edit an abstract that has been saved, but not yet submitted, please click ‘Edit’ below. This website works best with Internet Explorer 9 (or higher) or the latest version of Firefox, Chrome or Safari browsers on PC or Macintosh.

ESCMID strongly supports the improvements of reporting of study results. For this reason, all Authors submitting randomized clinical trials (RCT), infection control intervention studies (including studies to improve compliance with interventions such as antibiotic stewardship, hand hygiene or care bundles), outbreak reports of nosocomial infection, and observational studies in epidemiology are kindly requested to consult the following abstract checklists (please click on the respective link to download the document) for reporting their research results:

STROBE (observational study in epidemiology)
ORION (infection control intervention study or nosocomial infection outbreak report)

Abstract submitters will need to indicate on the abstract submission form which checklist was used.

Further information on these checklists is available at: www.equator-network.org


1.      Abstracts may be submitted online only. Abstracts submitted via fax or email will not be accepted.

2.      All abstracts must be submitted and presented in English using UK English spelling.

3.      Abstracts must contain original material neither published nor presented elsewhere prior to 25 April 2015.

4.      Please structure your abstract using the following headings:


Tables: Authors can include a maximum of 1 table (of up to 10 rows x 10 columns) per abstract. Words within the table count into the total of the maximum words allowed.
Pictures/Graphs: Authors can include a maximum of 1 picture/graph. The file size of each picture/graph should not exceed 500 KB. The maximum pixel size of the graph/picture is 600(w) x 800(h) pixels.

5.    Abstract titles must be submitted in Upper and lower case and to include any special characters, special words that need to be capitalized or in italics. Abstract titles will be posted as submitted.

6.      The abstract text may not be longer than maximum 450 words.  

You can upload graphs and images in JPG, PNG and GIF format, of high resolution only.

7.      Spelling Guidelines: The International System of Units (SI) should be used wherever appropriate. Genus and species names should be written in full on first mention and then abbreviated on subsequent mention.

         The following general rules apply (examples in brackets): 

  • Systematic names (genus, family and higher orders): capitalised (Chlamydia, Enterobacteriaceae, Picornaviridae). 
  • Non-English expressions: non-English expressions in English texts are written in italics, e.g. force majeure, in vitro/in vivo, ad hoc, ex officio
  • Taxonomic names: are to be italicised, e.g. Staphylococcus aureus, Clostridium difficile
  • Non-systematic names (e.g. plural): lower case (Group A streptococci, mycobacteria, chlamydiae).
  • Generic drug names: lower case (penicillin).
  • Avoid using brand names; if needed: capitalised with trademark symbol (Rocephin®).
  • Diseases and viruses: lower case (hepatitis, herpes zoster, herpesvirus, West Nile virus).
  • Please observe standard English grammar rules including a space after full stops and commas.
  • Only common abbreviations approved for use by CMI can be used without definition. 

For details consult the ESCMID website at Clinical Microbiology & Infection (CMI), Guidelines for Authors.

        Guidelines for Authors
8.     Authors should indicate their presentation preference:

Poster only
Oral or poster presentation

9.     Authors are asked to enter a minimum of 3 keywords to better define the abstract content.

10.   After having submitted your abstract, you will receive a confirmation by email (please make sure to state your correct email address!). Should you wish to make corrections to an abstract already submitted or if you wish to submit other abstracts later, you may use your personal access codes.
Corrections to abstracts can only be made up to the Late-breaker abstract submission deadline of 10 March 2015.

11.   Abstracts will be subject to a blind peer review by at least 3 members of the Programme Committee and external experts.

12.   Authors will be notified of acceptance by 10 April 2015 by email.

13.   Abstract authors must register for the congress by 15 April 2015 or advise us of withdrawal by this date.

14.   If an abstract is accepted, the presenting author must attend the congress and present it in person. If a presenting author withdraws an abstract after 15 April 2015 or does not attend the session for which he or she has been scheduled, a penalty will incur prohibiting the author from presenting papers at ECCMID meetings for a period of 3 years. Those subject to this penalty will be informed in writing.